Pharmac to disestablish its Māori advisory group

Screenshot of the PHARMAC website

12 Nov 2024

RNZ

Pharmac has decided to disestablish its Māori advisory group – something the advisory group’s former chairperson says will compromise its ability to deliver for Māori.

In a statement, the chairperson of the drug funding agency, Paula Bennett, said the board made the decision to disestablish the group in order to put more focus on other partnership arrangements already in place.

These include the four Māori health professional bodies, iwi Māori Partnership Boards, and the Hauora Māori Advisory Committee within the Ministry of Health, she said.

Read more

 

Other stories

Academic Literature
New Zealand Pae Ora Healthcare Reforms 2022: Viable by Design? A Qualitative Study Using the Viable System Model

New Zealand Pae Ora Healthcare Reforms 2022: Viable by Design? A Qualitative Study Using the Viable System Model

The New Zealand (NZ) Pae Ora (Healthy Futures) health reforms came into effect in July 2022 with the establishment of Health New Zealand (HNZ) (Te Whatu Ora) and the Māori Health Authority (MHA) (Te Aka Whai Ora) – the organisations charged for healthcare provision...

Key issues

HEALTH SERVICES AND SYSTEMS

Covering developments in the provision, funding and organisation of health care services.

EQUITY

Exploring the impacts of the health system on minorities within the population, notably including Māori, Pacifica, Asians and LGBTQI.

DRUGS, DEVICE AND DIAGNOSTICS

Covering prescription medicines and medical devices.

PUBLIC HEALTH

Focusing on efforts to promote health and prevent disease through social and economic interventions.

DIGITAL HEALTH

Exploring the potential digital transformation to provide a more connected and accessible health system.

TE TIRITI

Monitoring how the health reforms and the performance of the health sector uphold Te Tiriti obligations.